Nosocomial Methicillin-Resistant and Methicillin-SusceptibleStaphylococcus AureusPrimary Bacteremia: At What Costs?

This publication has 22 references indexed in Scilit:

• Ampicillin, Sulbactam, and Rifampin Combination Treatment of Experimental Methicillin-Resistant Staphylococcus aureus Endocarditis in Rabbits
  The Journal of Infectious Diseases, 1995
• Nosocomial Bloodstream Infection in Critically III Patients
  JAMA, 1994
• Methicillin-Resistant Staphylococcus aureus in U.S. Hospitals, 1975–1991
  Infection Control & Hospital Epidemiology, 1992
• Slow Response to Vancomycin or Vancomycin plus Rifampin in Methicillin-resistant Staphylococcus aureus Endocarditis
  Annals of Internal Medicine, 1991
• Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci
  Antimicrobial Agents and Chemotherapy, 1991
• Comparative Efficacy of Amoxicillin-Clavulanate, Cloxacillin, and Vancomycin Against Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus Endocarditis in Rats
  The Journal of Infectious Diseases, 1989
• Cost of nosocomial infection: Relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections
  American Journal of Infection Control, 1988
• Combination Antimicrobial Therapy forStaphylococcus aureusEndocarditis in Patients Addicted to Parenteral Drugs and in Nonaddicts
  Annals of Internal Medicine, 1982
• Epidemiologie Studies of an Outbreak of Nosocomial Methicillin-ResistantStaphylococcus aureusInfections
  Infection Control, 1981
• Morbidity/Mortality and Economics of Hospital-Acquired Blood Stream Infections
  Southern Medical Journal, 1977